Pathogenic germline variants identified in pNEN patients during genetic testing
Endocrine Oncology · 01.01.2026 · 6 (1)
DOI: 10.1530/eo-25-0088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Oncology, online erschienen am 15.05.2026. Verfasst von Tara Arouchian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Samuel Oschin Comprehensive Cancer Center, Cedars Sinai Medical Center, Los Angeles, California, USA. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Poor outcomes in pancreatic neuroendocrine neoplasms (pNENs) partially result from the inability to identify early-stage disease in patients. Prevention strategies have focused on identifying high-risk patients through genetic susceptibility genes. This study aims to report the incidence of pathogenic germline variants (PGVs) in pNEN. 129 pNEN patients that underwent germline testing with Invitae between September 5, 2019, and February 15, 2022, were retrospectively analyzed. PGVs were found in 14.7% (19/129) of pNENs. PGVs in pancreatitis genes were detected in 7.7% (3/39) of the 39 pNEN patients with an available pancreatitis panel. CFTR alterations were the most common pancreatitis-associated gene identified (5.1%, 2/39). MUTYH alterations were the most frequently detected (3.9%, 5/129) PGV in pNENs. DNA or base repair PGVs were found in 7.8% (10/129). Our findings suggest that germline testing may play a role in the standard-of-care management of pNEN. MUTYH alterations merit further evaluation as a potential risk factor for pNEN.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Samuel Oschin Comprehensive Cancer Center, Cedars Sinai Medical Center, Los Angeles, California, USA.
- Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.
ORCID-Profile: Tara Arouchian
Zitieren
APA
Arouchian, T., Gangi, A., Fung, K. W., Dumitra, T., Levi, A., Osipov, A., & Hendifar, A. E. (2026). Pathogenic germline variants identified in pNEN patients during genetic testing. Endocrine Oncology, 6(1). https://doi.org/10.1530/eo-25-0088
Vancouver
Arouchian T, Gangi A, Fung KW, Dumitra T, Levi A, Osipov A, et al. Pathogenic germline variants identified in pNEN patients during genetic testing. Endocrine Oncology. 2026;6(1). doi:10.1530/eo-25-0088
BibTeX
@article{Arouchian2026,
author = {Arouchian, Tara and Gangi, Alexandra and Fung, Ka Wing and Dumitra, Teodora and Levi, Abrahm and Osipov, Arsen and Hendifar, Andrew E},
title = {Pathogenic germline variants identified in pNEN patients during genetic testing},
journal = {Endocrine Oncology},
year = {2026},
volume = {6},
number = {1},
doi = {10.1530/eo-25-0088}
}
EUVIMED